Victoria Bandyk, chief operating officer of the Bioscience Group, provides insights into the unique added value and the international development of this comprehensive group of companies, which aims to support local and international companies in positioning, registering, and promoting medicines across targeted European and Asian markets, finding strategic partners across the value chain, as well as obtaining marketing authorizations and certifications for quality and safety controls.
Could you briefly introduce Bioscience and the scope of the group’s activities to our international readers?
"Overall, Bioscience Group is partnering with over 50 pharmaceutical and healthcare companies – a large share of them being located in the EU."
